Clarity, along with most Aussie biotech, has been caught in a double whirlwind: a sharp sell-off in US healthcare stocks and ...

A study of 53,402 employees at the Cleveland Clinic found those who received the 2024-2025 flu vaccine were 27% more likely ...

Markets might have needed a break last week—but this week, they roared back to life. Call it the Trump whiplash effect.

Forecasts for more cash rate cuts by the RBA in 2025 have stoked demand for gold, as lines regularly form outside a Martin ...

After the whiplash markets have given everyone in the past few weeks, our experts thought an extra bonus from the Easter ...

This year the Hang Seng Index has soared, beating the US markets and its global peers. Chinese companies delivered strong ...

That kind of revenue growth makes the financial results from 100-baggers like Afterpay ( ASX: APT) and Pro Medicus ( ASX: PME ...

The beginning of 2025 saw increasing policy uncertainty due to Trump's tariff threats, the DOGE cuts, and curbs on ...

Money is made by buying great companies at attractive prices. Such opportunities only come along during periods of heightened ...

The signal has occurred 74 times since 1990. US markets ended higher 1 & 5 years later 100% of the time. Here's what we're ...

Phil King discusses the Opthea fiasco, his current outlook and whether we’ve seen the bottom in equity markets.

“Active managers have had a hard time, but when the tide goes out what you own matters a lot at a stock level. Getting asset ...